News & Analysis on Clinical Trial Services & Contract Research And Development
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Pfizer and AstraZeneca naming R&D leaders and appointments at APV and Lonza.
Irish pharmaceutical company Elan says most potential investors are positive about proposal to spin-off drug delivery unit.
Siegfried is to supply at least 60 per cent of Jazz Pharmaceutical’s global requirement for sodium oxybate, the active pharmaceutical ingredient (API) in Xyrem.
Claris has initiated a recall of three antibiotics it manufactures, which are also sold by Sagent, Pfizer and West-Ward, after the FDA warned of contamination.
Ampac Flexibles continues to utilise its High-Speed (HS) Laminate technology by launching its laminate films – a product, which the makers claim will heat seal at temperatures 40 degrees lower than standard laminate materials.
Hungary-based Ubichem Research has gained approval to supply cGMP radiolabelled APIs in the European Union (EU), positioning it to benefit from increased demand.
The EMA has published its thoughts on monitoring overseas trials and will seek to establish an international network of regulators to develop and implement a robust oversight framework.
New research could make it possible for scientists to use silicon particles as an effective drug delivery system that enables fragile small interfering RNA (siRNA) based drugs to be directly transported to the disease’s location.